167 related articles for article (PubMed ID: 21283701)
1. Constitutive activation of the thyroid-stimulating hormone receptor (TSHR) by mutating Ile691 in the cytoplasmic tail segment.
Liu Z; Fan F; Xiao X; Sun Y
PLoS One; 2011 Jan; 6(1):e16335. PubMed ID: 21283701
[TBL] [Abstract][Full Text] [Related]
2. Proper targeting and activity of a nonfunctioning thyroid-stimulating hormone receptor (TSHr) combining an inactivating and activating TSHr mutation in one receptor.
Agretti P; De Marco G; Collecchi P; Chiovato L; Vitti P; Pinchera A; Tonacchera M
Eur J Biochem; 2003 Sep; 270(18):3839-47. PubMed ID: 12950268
[TBL] [Abstract][Full Text] [Related]
3. Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.
Holzapfel HP; Bergner B; Wonerow P; Paschke R
Eur J Endocrinol; 2002 Jul; 147(1):109-16. PubMed ID: 12088927
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
5. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
6. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.
Grasberger H; Van Sande J; Hag-Dahood Mahameed A; Tenenbaum-Rakover Y; Refetoff S
J Clin Endocrinol Metab; 2007 Jul; 92(7):2816-20. PubMed ID: 17456567
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of five constitutively activating thyrotrophin receptor mutations.
Wonerow P; Chey S; Führer D; Holzapfel HP; Paschke R
Clin Endocrinol (Oxf); 2000 Oct; 53(4):461-8. PubMed ID: 11012571
[TBL] [Abstract][Full Text] [Related]
8. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
9. Functional significance of the thyrotropin receptor germline polymorphism D727E.
Sykiotis GP; Neumann S; Georgopoulos NA; Sgourou A; Papachatzopoulou A; Markou KB; Kyriazopoulou V; Paschke R; Vagenakis AG; Papavassiliou AG
Biochem Biophys Res Commun; 2003 Feb; 301(4):1051-6. PubMed ID: 12589819
[TBL] [Abstract][Full Text] [Related]
10. A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism.
Alberti L; Proverbio MC; Costagliola S; Weber G; Beck-Peccoz P; Chiumello G; Persani L
Eur J Endocrinol; 2001 Sep; 145(3):249-54. PubMed ID: 11517004
[TBL] [Abstract][Full Text] [Related]
11. A family with a novel TSH receptor activating germline mutation (p.Ala485Val).
Akcurin S; Turkkahraman D; Tysoe C; Ellard S; De Leener A; Vassart G; Costagliola S
Eur J Pediatr; 2008 Nov; 167(11):1231-7. PubMed ID: 18175146
[TBL] [Abstract][Full Text] [Related]
12. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
Lueblinghoff J; Eszlinger M; Jaeschke H; Mueller S; Bircan R; Gozu H; Sancak S; Akalin S; Paschke R
Thyroid; 2011 Mar; 21(3):221-9. PubMed ID: 21190443
[TBL] [Abstract][Full Text] [Related]
13. Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism.
Claus M; Maier J; Paschke R; Kujat C; Stumvoll M; Führer D
Thyroid; 2005 Sep; 15(9):1089-94. PubMed ID: 16187920
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor.
Claus M; Neumann S; Kleinau G; Krause G; Paschke R
J Mol Med (Berl); 2006 Nov; 84(11):943-54. PubMed ID: 16955277
[TBL] [Abstract][Full Text] [Related]
15. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia.
Tonacchera M; Van Sande J; Cetani F; Swillens S; Schvartz C; Winiszewski P; Portmann L; Dumont JE; Vassart G; Parma J
J Clin Endocrinol Metab; 1996 Feb; 81(2):547-54. PubMed ID: 8636266
[TBL] [Abstract][Full Text] [Related]
16. The Pathogenic TSH β-subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR.
Kalveram L; Kleinau G; Szymańska K; Scheerer P; Rivero-Müller A; Grüters-Kieslich A; Biebermann H
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703413
[TBL] [Abstract][Full Text] [Related]
17. Cloning of the cat TSH receptor and evidence against an autoimmune etiology of feline hyperthyroidism.
Nguyen LQ; Arseven OK; Gerber H; Stein BS; Jameson JL; Kopp P
Endocrinology; 2002 Feb; 143(2):395-402. PubMed ID: 11796491
[TBL] [Abstract][Full Text] [Related]
18. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor.
Grüters A; Schöneberg T; Biebermann H; Krude H; Krohn HP; Dralle H; Gudermann T
J Clin Endocrinol Metab; 1998 May; 83(5):1431-6. PubMed ID: 9589634
[TBL] [Abstract][Full Text] [Related]
19. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.
Führer D; Wonerow P; Willgerodt H; Paschke R
J Clin Endocrinol Metab; 1997 Dec; 82(12):4234-8. PubMed ID: 9398746
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid.
Krause K; Boisnard A; Ihling C; Ludgate M; Eszlinger M; Krohn K; Sinz A; Fuhrer D
Int J Biochem Cell Biol; 2012 Feb; 44(2):290-301. PubMed ID: 22074661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
